FP7H2020HORIZON
Avantea SRL
- Country
- ITItaly
- Defence projects
- 0
- Projects, all programmes
- 14
- As coordinator
- 0
- EU contribution (CORDIS)
- EUR 4,881,759
- Active
- 2008 to 2024
Projects
14 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| NHPigReducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models | HORIZON | 2024 | Participant | EUR 200,625 |
| WhyNotDryToward consolidation of germplasm and cell reversible drying through knowledge transfer. | HORIZON | 2023 | Participant | EUR 27,600 |
| DRYNETSetting an interdisciplinary/sectorial/international research network to explore dry storage as an alternative strategy for cells/germplasm biobanking | H2020 | 2017 | Participant | EUR 27,000 |
| POLYBOOSTPOLYBOOST: Renovating the Polyclonal Immunotherapy | H2020 | 2016 | Participant | EUR 0 |
| EU-rhythmyMolecular strategies to treat inherited arrhythmias | H2020 | 2015 | Participant | EUR 380,000 |
| FECUNDOptimisation of early reproductive success in dairy cattle through the definition of new traits and improved reproductive biotechnology | FP7 | 2013 | Participant | EUR 285,000 |
| MITCAREMitochondrial Medicine: developing treatments of OXPHOS-defects in recombinant mammalian models. | FP7 | 2013 | Participant | EUR 401,000 |
| EPIHEALTHNETEpiHealthNet | FP7 | 2013 | Participant | EUR 345,706 |
| XENOISLETMacroencapsulated Porcine Pancreatic Islets to cure Diabetes Mellitus type 1/2 | FP7 | 2013 | Participant | EUR 914,500 |
| TRANSLINKDefining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves | FP7 | 2013 | Participant | EUR 1,054,789 |
| SCR&TOXStem Cells for Relevant Efficient Extended and Normalized Toxicology | FP7 | 2011 | Participant | EUR 155,570 |
| EPIHEALTHLinking perturbed maternal environment during periconceptional development, due to diabetes, obesity or assisted reproductive technologies, and altered health during ageing. | FP7 | 2011 | Participant | EUR 364,640 |
| PLURISYSSystems biology approaches to understand cell pluripotency Acronym: PluriSys | FP7 | 2009 | Participant | EUR 328,000 |
| ESNATSEmbryonic Stem cell-based Novel Alternative Testing Strategies | FP7 | 2008 | Participant | EUR 397,329 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.